Women in Dual With Dolutegravir
NCT05735535
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
290
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Antiviral Agents
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS